Dermatology NewsDebate: Should biologics be used for milder cases of psoriasis?April 26, 2021PsoriasisPsoriatic Arthritis
Dermatology NewsClearance rates higher with bimekizumab vs. secukinumab in phase 3 psoriasis studyApril 24, 2021Psoriasis
Dermatology NewsStudy aims to enhance understanding of ‘tremendously understudied’ prurigo nodularisApril 16, 2021Medical DermatologyPsoriasisAtopic DermatitisMixed Topics
Dermatology NewsSecukinumab brings high PASI 75 results in 6- to 17-year-olds with psoriasisApril 12, 2021PsoriasisPediatrics
Dermatology NewsResearchers stress importance of second COVID-19 vaccine dose for infliximab usersApril 6, 2021COVID-19 UpdatesPsoriatic ArthritisPediatricsPsoriasis
Dermatology NewsBimekizumab superior to adalimumab in head-to-head psoriasis studyApril 6, 2021PsoriasisPsoriatic Arthritis
Dermatology NewsNational Psoriasis Foundation recommends some stop methotrexate for 2 weeks after J&J vaccineMarch 31, 2021PsoriasisCOVID-19 Updates
Dermatology NewsTo improve psoriatic arthritis outcomes, address common comorbiditiesMarch 12, 2021Psoriatic ArthritisPsoriasis
Dermatology NewsRecent psoriasis pathophysiology insights carry treatment implicationsMarch 4, 2021PsoriasisPsoriatic Arthritis
